Hansen Gwenn
Chief Scientific Officer at NRIX
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 38
- Latest Sep 1, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NRIXNurix Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NRIXNo planOct 30 2025
Sold 4,087 shares at $12.80 ($52k)
Hansen Gwenn, Chief Scientific Officer
No 10b5-1 planSold 5.1% of holdings ($1M position)76,751 shares left1.2x usual sizeFiling
- 2 Form 4 sale NRIXNo planJan 30 +92 days
Sold 4,895 shares at $16.60 ($81k)
Hansen Gwenn, Chief Scientific Officer
No 10b5-1 planSold 5.5% of holdings ($1.5M position)83,672 shares left1.4x usual sizeFiling
- 3 Form 4 sale NRIXNo planApr 30 +90 days
Sold 3,214 shares at $16.65 ($54k)
Hansen Gwenn, Chief Scientific Officer
No 10b5-1 planSold 2.6% of holdings ($2.1M position)120,399 shares left0.9x usual sizeFiling
- 4 Form 4 sale NRIXRoutineJun 25 +56 days
Sold 5,394 shares at $20.00 ($108k)
Hansen Gwenn, Chief Scientific Officer
10b5-1 planSold 4.5% of holdings ($2.4M position)115,005 shares left1.5x usual sizeFiling
- 5 Form 4 sale NRIXNo planJul 30 +35 days
Sold 3,847 shares at $23.38 ($90k)
Hansen Gwenn, Chief Scientific Officer
No 10b5-1 planSold 3.1% of holdings ($2.9M position)121,338 shares left1x usual sizeFiling
- 6 Form 4 sale NRIXRoutineAug 4 +5 days
Sold 4,111 shares at $24.36 ($100k)
Hansen Gwenn, Chief Scientific Officer
10b5-1 planSold 3.4% of holdings ($3M position)117,227 shares left1.1x usual sizeFiling
- 7 Form 4 sale NRIXRoutineAug 5 +1 day
Sold 4,356 shares at $25.00 ($109k)
Hansen Gwenn, Chief Scientific Officer
10b5-1 planSold 3.6% of holdings ($3M position)117,227 shares left1.1x usual sizeFiling
- 8 Form 4 sale NRIXRoutineSep 1 +27 days
Sold 1,452 shares at $25.47 ($37k)
Hansen Gwenn, Chief Scientific Officer
10b5-1 planSold 1.2% of holdings ($3M position)117,227 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (38)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 1,452 | $37k | 1.2% | Routine | SEC |
| Aug 5, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 4,356 | $109k | 3.6% | Routine | SEC |
| Aug 4, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 4,111 | $100k | 3.4% | Routine | SEC |
| Jul 30, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 3,847 | $90k | 3.1% | No plan | SEC |
| Jun 25, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 5,394 | $108k | 4.5% | Routine | SEC |
| Apr 30, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 3,214 | $54k | 2.6% | No plan | SEC |
| Jan 30, 2026 | NRIX | Chief Scientific Officer | Form 4 sale | 4,895 | $81k | 5.5% | No plan | SEC |
| Oct 30, 2025 | NRIX | Chief Scientific Officer | Form 4 sale | 4,087 | $52k | 5.1% | No plan | SEC |
| Jul 30, 2025 | NRIX | Chief Scientific Officer | Form 4 sale | 4,308 | $52k | 5.9% | No plan | SEC |
| Apr 30, 2025 | NRIX | Chief Scientific Officer | Form 4 sale | 3,377 | $39k | 5.2% | No plan | SEC |
| Jan 30, 2025 | NRIX | Chief Scientific Officer | Form 4 sale | 3,690 | $73k | 6.2% | No plan | SEC |
| Oct 30, 2024 | NRIX | Chief Scientific Officer | Form 4 sale | 3,437 | $84k | 6.4% | No plan | SEC |
| Jul 30, 2024 | NRIX | Chief Scientific Officer | Form 4 sale | 3,408 | $70k | 7.0% | No plan | SEC |
| Apr 30, 2024 | NRIX | Chief Scientific Officer | Form 4 sale | 2,007 | $24k | 4.8% | No plan | SEC |
| Jan 30, 2024 | NRIX | Chief Scientific Officer | Form 4 sale | 2,334 | $19k | 6.0% | No plan | SEC |
| Oct 31, 2023 | NRIX | Chief Scientific Officer | Form 4 sale | 1,633 | $8k | 4.6% | No plan | SEC |
| Jul 31, 2023 | NRIX | Chief Scientific Officer | Form 4 sale | 1,884 | $18k | 5.9% | No plan | SEC |
| May 1, 2023 | NRIX | Chief Scientific Officer | Form 4 sale | 1,136 | $11k | 4.1% | No plan | SEC |
| Jan 30, 2023 | NRIX | Chief Scientific Officer | Form 4 sale | 1,412 | $17k | 5.8% | Unusual | SEC |
| Oct 31, 2022 | NRIX | Chief Scientific Officer | Form 4 sale | 1,165 | $15k | 5.2% | Plan not stated | SEC |
| Aug 1, 2022 | NRIX | Chief Scientific Officer | Form 4 sale | 1,186 | $19k | 5.8% | Plan not stated | SEC |
| May 2, 2022 | NRIX | Chief Scientific Officer | Form 4 sale | 1,098 | $13k | 6.0% | Plan not stated | SEC |
| Jan 3, 2022 | NRIX | Chief Scientific Officer | Form 4 sale | 1,828 | $53k | 11.4% | Unusual | SEC |
| Dec 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $12k | 2.7% | Plan not stated | SEC |
| Nov 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $13k | 2.7% | Plan not stated | SEC |
| Oct 27, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $14k | 2.7% | Plan not stated | SEC |
| Oct 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $12k | 2.7% | Plan not stated | SEC |
| Sep 7, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 1,600 | $56k | 10.1% | Unusual | SEC |
| Sep 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $13k | 2.7% | Plan not stated | SEC |
| Aug 2, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $12k | 2.8% | Plan not stated | SEC |
| Jul 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $11k | 2.8% | Plan not stated | SEC |
| Jun 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $11k | 2.8% | Plan not stated | SEC |
| May 3, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 800 | $28k | 5.5% | Plan not stated | SEC |
| Apr 5, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $14k | 2.8% | Plan not stated | SEC |
| Apr 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 400 | $13k | 2.8% | Plan not stated | SEC |
| Mar 16, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 800 | $36k | 5.5% | Plan not stated | SEC |
| Mar 1, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 800 | $29k | 5.5% | Plan not stated | SEC |
| Feb 18, 2021 | NRIX | Chief Scientific Officer | Form 4 sale | 800 | $29k | 6.3% | Plan not stated | SEC |